U.S. Building Stock News

Insmed Incorporated recently reported first-quarter 2026 results showing a narrower net loss of US$163.56 million and reiterated 2026 revenue guidance for BRINSUPRI of at least US$1 billion and ARIKAYCE of US$450 million to US$470 million. The company is also set to showcase six presentations from its respiratory portfolio at ATS 2026, highlighting both new clinical data and its role in addressing underdiagnosis of bronchiectasis through an independently run quality improvement...

Event context and recent price performance Tapestry (TPR) has drawn attention after recent trading saw the stock at a last close of US$131.73, with the price down about 12% over the past month and roughly 15% over the past 3 months. See our latest analysis for Tapestry. While the recent 1 month share price return is down 12.36% and the 3 month share price return is down 14.83%, the 1 year total shareholder return of 59.85% and 5 year total shareholder return of 222.90% show that longer...

If you are wondering whether Victory Capital Holdings at US$87.07 is priced attractively or fully reflecting its prospects, the key question is what you are actually paying for today. The stock has posted returns of 7.1% over the last 7 days, 28.4% over 30 days, 35.8% year to date and 38.5% over the past year, which naturally raises questions about how much value is already in the price. Recent coverage has focused on Victory Capital Holdings as a capital markets stock with strong historical...

WEBTOON Entertainment (WBTN) opened 2026 with Q1 revenue of US$320.9 million and a reported net loss of US$9.5 million, which translated into EPS of US$0.07 loss, alongside trailing twelve month revenue of about US$1.4 billion and a trailing EPS loss of roughly US$2.54. Over recent quarters the company has seen revenue range between US$325.7 million and US$378.0 million while quarterly EPS losses moved between roughly US$0.03 and US$2.36. This sets the backdrop for today’s US$12.16 share...

AST SpaceMobile (ASTS) opened Q1 2026 with total revenue of US$14.7 million and a basic EPS loss of US$0.66, alongside a net income loss of US$191.0 million. This sets a clear tone for what remains a scale up story rather than a profitability one. The company reported an increase in revenue from US$0.7 million in Q1 2025 to US$14.7 million in Q1 2026, while quarterly basic EPS moved from a loss of US$0.20 to a loss of US$0.66. This leaves investors focused on how quickly future top line...

Under Armour (UAA) has reported a challenging set of FY 2026 numbers, with Q3 revenue at US$1.3 billion and a basic EPS loss of US$1.01. Trailing 12 month figures show revenue of US$5.0 billion and a basic EPS loss of US$1.22, alongside a net loss of US$519.7 million. Over recent quarters, revenue has moved between US$1.1 billion and US$1.4 billion, while EPS shifted from a profit of US$0.39 in FY 2025 Q2 to successive quarterly losses through FY 2026. This has created a results season in...

VAALCO Energy (NYSE:EGY) opened 2026 with Q1 revenue of US$62.6 million and a basic EPS loss of US$0.90, as the company also reported a Q1 net loss of US$93.8 million. Over recent quarters, revenue has moved from US$121.7 million in Q4 2024 to US$110.3 million in Q1 2025, US$96.9 million in Q2 2025, US$61.0 million in Q3 2025, and US$91.0 million in Q4 2025. EPS shifted from US$0.11 in Q4 2024 to US$0.56 in Q1 2025, US$0.37 in Q2 2025, US$0.01 in Q3 2025, and a loss of US$0.56 in Q4 2025...

Leonardo DRS (DRS) has attracted fresh attention after reporting first quarter 2026 results, with higher sales and net income year on year and an increase in its full year revenue guidance, alongside improving analyst sentiment. See our latest analysis for Leonardo DRS. At a share price of $42.87, Leonardo DRS has a 1-day share price return of 3.33% and a year to date share price return of 23.26%. Its 3-year total shareholder return of 187.09% points to strong longer term compounding even...

United Parks & Resorts (PRKS) opened Q1 2026 with total revenue of US$278.3 million and a reported loss of US$34.1 million, translating to basic EPS of US$0.69 in the red as the seasonally softer quarter reset the earnings run rate investors saw through 2025. Over recent quarters the company has seen revenue move between US$286.9 million in Q1 2025 and a peak of US$511.9 million in Q3 2025, while basic EPS has ranged from a loss of US$0.29 in Q1 2025 to a high of US$1.62 in Q3 2025. This...

C3.ai, Inc. recently reported preliminary results for its fourth quarter and full fiscal year to April 30, 2026, alongside a restructuring plan and leadership changes that saw founder Thomas M. Siebel return as Chief Executive Officer while Stephen Ehikian remained President. The combination of sharp revenue declines, workforce reductions, and a renewed focus on cost savings and profitability highlights how investor expectations across AI software are shifting toward margins and cash...

Harrow (HROW) Kicks Off 2026 With Mixed Top Line and a Return to Losses Harrow (HROW) opened 2026 with Q1 revenue of US$44.2 million and a basic EPS loss of US$0.74, while trailing twelve month revenue stood at US$268.7 million and trailing EPS was a loss of US$0.40. The company has seen quarterly revenue move from US$47.8 million in Q1 2025 to US$89.1 million in Q4 2025 before landing at US$44.2 million in Q1 2026. Over the same period, EPS swung from a loss of US$0.50 in Q1 2025 to a profit...

Legend Biotech’s Earnings Spark Fresh Interest in the Stock Legend Biotech (LEGN) recently released first quarter 2026 results, reporting revenue of US$305.1 million and a net loss of US$54.3 million. This compares with revenue of US$195 million and a net loss of US$101 million a year earlier. See our latest analysis for Legend Biotech. Legend Biotech’s 1 day share price return of 10.48% came alongside the earnings release, while the 30 day share price return of 55.62% suggests momentum has...

Clear Secure (YOU) is back in focus after releasing first quarter results and issuing second quarter revenue guidance that points to continued growth, along with updates on its share repurchase activity and quarterly dividend. See our latest analysis for Clear Secure. Clear Secure's recent earnings, revenue guidance and ongoing capital returns have come alongside strong share price momentum, with a 30 day share price return of 24.84% and a 90 day share price return of 77.14%, while the 1 year...

ADMA Biologics (ADMA) stock has been in focus after short seller Culper Research alleged channel stuffing related to ASCENIV, prompting multiple securities law firms to launch investigations and potential class action lawsuits. See our latest analysis for ADMA Biologics. At a share price of $8.41, ADMA’s recent trading reflects sharp swings, with a 1-day share price gain of 6.73% sitting against a 7-day decline of 17.95% and a 90-day fall of 48.34%. The 5-year total shareholder return remains...

Fidelity National Information Services (NYSE:FIS) has secured a major contract with Commonwealth Bank of Australia for its cloud-native FIS Data Integrity Manager reconciliation platform. The deal sits alongside recent product and client updates, including work with M1 and the rollout of the Lyriq platform and Project Keystone. For a company built around payment processing, core banking systems, and financial software, NYSE:FIS is leaning further into cloud-native, enterprise SaaS tools...

Wondering if Union Pacific at around US$265.60 is offering you fair value or a potential mispricing opportunity? This article walks through the key signals that matter for long term investors. The stock has returned 0.6% over the past week, 6.0% over the last month, 14.5% year to date and 19.1% over the past year, which gives useful context before weighing what that price might imply about future risk and reward. Recent interest around Union Pacific has been supported by ongoing attention on...

Energy Services of America (ESOA) just posted Q2 2026 results with revenue of US$93.2 million and basic EPS of US$0.01, setting a more muted tone after a stronger run in prior quarters. The company has seen quarterly revenue move from US$76.7 million in Q2 2025 to US$93.2 million in Q2 2026, while basic EPS has swung from a Q2 2025 loss of US$0.41 to a slim profit of US$0.01. This puts the focus squarely on how consistently it can rebuild margins from here. See our full analysis for Energy...

Atlanta Braves Holdings (BATR.K) has opened Q1 2026 with revenue of US$72.0 million and a reported loss of US$40.5 million, translating to basic EPS of US$0.63 in the red as the seasonally weaker part of the baseball calendar continues to weigh on reported margins. The company has seen quarterly revenue move from US$47.2 million in Q1 2025 to US$72.0 million in Q1 2026, while basic EPS in the first quarter shifted from a loss of US$0.66 to a loss of US$0.63. This sets up an earnings print...

Lucid Group earnings trigger fresh focus on losses and funding Lucid Group (LCID) is back in the spotlight after first quarter results showed sales of US$282.47 million and a net loss of US$1,028.34 million, sharpening attention on cash burn and funding. See our latest analysis for Lucid Group. The share price has retreated in recent months, with a 30 day share price return of down 29.95% and a 90 day share price return of down 40.20% contributing to a 1 year total shareholder return of down...

FONAR (FONR) has just posted its Q3 2026 results, with Q2 fiscal 2026 revenue at US$25.5 million and basic EPS of US$0.30, alongside a trailing twelve month net profit margin of 6.8%. Over recent quarters the company has seen revenue move between US$24.9 million and US$27.3 million, while quarterly basic EPS has ranged from US$0.11 to US$0.46, setting the backdrop for trailing twelve month EPS of about US$1.10. With earnings quality described as high but margins a touch softer than a year...

Radiant Logistics (RLGT) has reported Q3 2026 revenue of US$214.1 million with basic EPS of US$0.10, alongside trailing 12 month revenue of US$893.5 million and basic EPS of US$0.34, providing a clear snapshot of its recent earnings power. The company has seen quarterly revenue move between US$214.0 million and US$264.5 million over the last six reported periods, with basic EPS ranging from US$0.03 to US$0.14. Trailing 12 month net income sits at US$16.2 million, so the latest print lands in...

AbCellera Biologics (NasdaqGS:ABCL) opened its Q1 2026 reporting season with recent quarterly revenue figures of US$44.9 million in Q4 2025 and a reported loss of US$8.9 million. This equates to basic EPS of US$0.03. On a trailing 12 month basis, revenue sits at US$75.1 million with EPS at US$0.49 and net income losses of US$146.4 million. Over the past year, the company has seen quarterly revenue move between US$4.2 million and US$44.9 million alongside quarterly EPS ranging from US$0.03 to...

If you are wondering whether CoStar Group at around US$33 a share is starting to look interesting, the key question is what you are really paying for today. The stock has been under pressure, with the share price down 5.3% over the past week, 9.4% over the past month, and 49.7% year to date, adding to a 56.0% decline over the last year and 59.6% over five years. Recent coverage has focused on how this extended share price slide has reset expectations around the company and sharpened...

Molina Healthcare recently held its 2026 Investor Day, where management outlined long-term financial targets through 2029, including plans for automation, AI-enabled operations, and segment-level growth priorities across Medicaid, Medicare, and Marketplace businesses. The company also projected premium expansion to nearly US$48.00 billions by 2027 while warning that regulatory and cost uncertainties could materially affect these ambitions. Next, we’ll examine how Molina’s new long-term...